Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Muhammad Naeem, Junhwan Bae, Murtada A Oshi, Min-Soo Kim, Hyung Ryong Moon, Bok Luel Lee, Eunok Im, Yunjin Jung & Jin-Wook Yoo. (2018) Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis. International Journal of Nanomedicine 13, pages 1225-1240.
Read now
Read now
Han Kang, Kwang-Ho Cha, Wonkyung Cho, Junsung Park, Hee Jun Park, Bo Kyung Sun, Sang-Min Hyun & Sung-Joo Hwang. (2016) Cyclosporine Amicellar delivery system for dry eyes. International Journal of Nanomedicine 11, pages 2921-2933.
Read now
Read now
Kieran Keohane, Mónica Rosa, Ivan S. Coulter & Brendan T. Griffin. (2016) Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres. Drug Development and Industrial Pharmacy 42:2, pages 245-253.
Read now
Read now
Melissa Guada, Victor Sebastián, Silvia Irusta, Esperanza Feijoó, María del Carmen Dios-Viéitez & María José Blanco-Prieto. (2015) Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. International Journal of Nanomedicine 10, pages 6541-6553.
Read now
Read now
Yue Yuan, Xin Che, Mingyi Zhao, Yan Wang, Yajun Liu, Anna Schwendeman & Sanming Li. (2015) Development of cyclosporine A microemulsion for parenteral delivery. Journal of Microencapsulation 32:3, pages 273-280.
Read now
Read now
Kai Wang, Jianping Qi, Tengfei Weng, Zhiqiang Tian, Yi Lu, Kaili Hu, Zongning Yin & Wei Wu. (2014) Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. International Journal of Nanomedicine 9, pages 4991-4999.
Read now
Read now
Pankaj Ranjan Karn, Su-Eon Jin, Benjamin Joon Lee, Bo Kyung Sun, Min-Soo Kim, Jong-Hyuk Sung & Sung-Joo Hwang. (2014) Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method. International Journal of Nanomedicine 9, pages 5079-5091.
Read now
Read now
Ling Zhang, Zhi-Liang Zhao, Xiao-Hong Wei & Jin-Hua Liu. (2013) Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles. International Journal of Nanomedicine 8, pages 601-610.
Read now
Read now
Pankaj Ranjan Karn, Wonkyung Cho, Hee-Jun Park, Jeong-Sook Park & Sung-Joo Hwang. (2013) Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method. International Journal of Nanomedicine 8, pages 365-377.
Read now
Read now
Articles from other publishers (58)
Frazer J. T. Buchanan, Shucheng Chen, Mark Harris & Morgan R. Herod. (2023) The hepatitis E virus ORF1 hypervariable region confers partial cyclophilin dependency. Journal of General Virology 104:11.
Crossref
Crossref
Yongpeng Huang, Hui Tang, Xiangyan Meng, Zitong Zhao, Yanli Liu, Dongxin Liu, Bo Chen & Zhiyun Zou. (2023) Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A. Pharmaceutics 15:9, pages 2204.
Crossref
Crossref
Yujie Li, Hui Ren, Fanlong Wang, Jianjun Chen, Lian Ma, Yang Chen, Xianbi Li, Yanhua Fan, Dan Jin, Lei Hou, Yonghong Zhou, Nemat O Keyhani & Yan Pei. (2023) Cell detoxification of secondary metabolites by P4-ATPase-mediated vesicle transport. eLife 12.
Crossref
Crossref
Mengqi Wan, Juhua Xiao, Jiejun Liu, Dou Yang, Ying Wang, Jieping Liu, Ling Huang, Fasheng Liu, Guanghua Xiong, Xinjun Liao, Huiqiang Lu, Zigang Cao & Shouhua Zhang. (2023) Cyclosporine A induces hepatotoxicity in zebrafish larvae via upregulating oxidative stress. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 266, pages 109560.
Crossref
Crossref
Soheil Haddadzadegan, Farid Dorkoosh & Andreas Bernkop-Schnürch. (2022) Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Advanced Drug Delivery Reviews 182, pages 114097.
Crossref
Crossref
S.R. Hashemi, H.A. Arab, B. Seifi & S. Muhammadnejad. (2021) A comparison effects of l-citrulline and l-arginine against cyclosporine-induced blood pressure and biochemical changes in the rats. Hipertensión y Riesgo Vascular 38:4, pages 170-177.
Crossref
Crossref
Hsing-Yu Hsu, Cheng-Wei Yang, Yue-Zhi Lee, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, Szu-Huei Wu, Jang-Yang Chang, Huey-Kang Sytwu, Chiung-Tong Chen & Shiow-Ju Lee. (2021) Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2. Frontiers in Pharmacology 12.
Crossref
Crossref
Benjamin J. Tombling, Yuhui Zhang, Yen-Hua Huang, David J. Craik & Conan K. Wang. (2021) The emerging landscape of peptide-based inhibitors of PCSK9. Atherosclerosis 330, pages 52-60.
Crossref
Crossref
Małgorzata Jurak, Klaudia Szafran, Pilar Cea & Santiago Martín. (2021) Analysis of Molecular Interactions between Components in Phospholipid-Immunosuppressant-Antioxidant Mixed Langmuir Films. Langmuir 37:18, pages 5601-5616.
Crossref
Crossref
Jennifer M. Corbett, Ian Hawthorne, Ivan S. Coulter & Karen English. (2021) Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease. Transplant Immunology 65, pages 101373.
Crossref
Crossref
Marie T. J. Bluntzer, James O'Connell, Terry S. Baker, Julien Michel & Alison N. Hulme. (2020)
Designing stapled peptides to inhibit
protein‐protein
interactions: An analysis of successes in a rapidly changing field
. Peptide Science 113:1.
Crossref
Crossref
Agnieszka Ewa Wiącek, Małgorzata Jurak, Agata Ładniak, Kacper Przykaza & Klaudia Szafran. (2020) Cyclosporine CsA—The Physicochemical Characterization of Liposomal and Colloidal Systems. Colloids and Interfaces 4:4, pages 46.
Crossref
Crossref
Masato Kobayashi, Keita Kondo, Chihiro Nakashima, Yudai Kida & Toshiyuki Niwa. (2020) Design of self-dispersible microsponge containing cyclosporine through wet milling and drop freeze-drying processes to improve dissolution behavior. Journal of Drug Delivery Science and Technology 57, pages 101577.
Crossref
Crossref
Giovanni Damiani, Alessia Pacifico, Dennis M. Linder, Paolo D.M. Pigatto, Rosalynn Conic, Ayman Grada & Nicola L. Bragazzi. (2019) Nanodermatology‐based solutions for psoriasis: State‐of‐the art and future prospects. Dermatologic Therapy 32:6.
Crossref
Crossref
Wenjuan Huang, Liang Wang, Baojingzi Zhang, Lei Zhou, Tiansong Zhang & Chao Quan. (2019) Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: A systematic review and network meta-analysis. Multiple Sclerosis and Related Disorders 35, pages 246-252.
Crossref
Crossref
Monica‐Y Choi, Yu‐Mee Wee, Yang‐Hee Kim, Sung Shin, Sung‐Eun Yoo & Duck‐Jong Han. (2019) Novel colchicine derivatives enhance graft survival after transplantation via suppression of T‐cell differentiation and activity. Journal of Cellular Biochemistry 120:8, pages 12436-12449.
Crossref
Crossref
Jingjing Wang, Qunfang Weng & Qiongbo Hu. (2019) Effects of Destruxin A on Silkworm’s Immunophilins. Toxins 11:6, pages 349.
Crossref
Crossref
Eun Hee Lee, Soojin Kim, Mi-Sun Choi, Se-Myo Park, Kyoung-Sik Moon, Seokjoo Yoon & Jung-Hwa Oh. (2019) Inhibition of PPARα target genes during cyclosporine A-induced nephrotoxicity and hepatotoxicity. Molecular & Cellular Toxicology 15:2, pages 185-197.
Crossref
Crossref
Kirill Gorshkov, Ni Sima, Wei Sun, Billy Lu, Wei Huang, Jameson Travers, Carleen Klumpp-Thomas, Samuel G. Michael, Tuan Xu, Ruili Huang, Emily M. Lee, Xiaodong Cheng & Wei Zheng. (2019) Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds. Translational Oncology 12:3, pages 441-452.
Crossref
Crossref
Neil J. Press, Emilie Joly & Peter Ertl. 2019.
157
187
.
Hossam H Tayeb & Frank Sainsbury. (2018) Nanoemulsions in drug delivery: formulation to medical application. Nanomedicine 13:19, pages 2507-2525.
Crossref
Crossref
Jie-Tao Chen, Xiao-Min Guo, Ping Yang & Qing Mu. (2018) Quantitative analysis of the cyclic peptide GG-8-6 in rat plasma using LC-MS/MS and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 159, pages 217-223.
Crossref
Crossref
Hongjun Huang, Qingqing Xiong, Ning Wang, Ruoyu ChenHua RenStefan Siwko, Honghui HanMingyao LiuMin Qian & Bing Du. (2018) Kisspeptin/GPR54 signaling restricts antiviral innate immune response through regulating calcineurin phosphatase activity. Science Advances 4:8.
Crossref
Crossref
Guangdong Lu, Zhenyu Jia, Qingquan Zu, Jinxing Zhang, Linbo Zhao & Haibin Shi. (2018) Inhibition of the cyclophilin A–CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats. Journal of Biological Chemistry 293:31, pages 12199-12208.
Crossref
Crossref
Ferdows Atiq, Edon Hameli, Annoek E. C. Broers, Jeanette K. Doorduijn, Teun Van Gelder, Louise M. Andrews, Birgit C. P. Koch, Jorie Versmissen & Brenda C. M. de Winter. (2018) Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals. European Journal of Clinical Pharmacology 74:6, pages 767-773.
Crossref
Crossref
A. G. Domratcheva, A. A. Zhgun, N. V. Novak & V. V. Dzhavakhiya. (2018) The Influence of Chemical Mutagenesis on the Properties of the Cyclosporine a High-Producer Strain Tolypocladium inflatum VKM F-3630D. Applied Biochemistry and Microbiology 54:1, pages 53-57.
Crossref
Crossref
Rakesh Kumar Tekade, Muktika Tekade, Prashant Kesharwani & Antony D’Emanuele. (2016) RNAi-combined nano-chemotherapeutics to tackle resistant tumors. Drug Discovery Today 21:11, pages 1761-1774.
Crossref
Crossref
Pengli Bu, Silpa Narayanan, Damon Dalrymple, Xingguo Cheng & Abu T.M. Serajuddin. (2016) Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant. European Journal of Pharmaceutical Sciences 91, pages 162-171.
Crossref
Crossref
Ferdows Atiq, Annoek E C Broers, Louise M Andrews, Jeanette K Doorduijn, Birgit C P Koch, Teun Van Gelder & Jorie Versmissen. (2016) A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib. European Journal of Clinical Pharmacology 72:6, pages 719-723.
Crossref
Crossref
Reza Mahjub, Robabeh Allahyar, Morteza Rafiee-Tehrani & Farid Abedin Dorkoosh. (2016) Preparation and characterization of nanoparticles composed of methylated N-(4-N,N-dimethyl aminobenzyl) chitosan for oral delivery of cyclosporine A. European Journal of Nanomedicine 8:2, pages 91-99.
Crossref
Crossref
Yeon-Hee Park, Kyoung Ah Min, Yun-Kyoung Song, Songhee Ham & Chong-Kook Kim. (2016) Chemically conjugated novel liposomal formulation for intravenous delivery of cyclosporin A. Colloids and Surfaces A: Physicochemical and Engineering Aspects 495, pages 229-237.
Crossref
Crossref
Melissa Guada, Ana Beloqui, M.N.V. Ravi Kumar, Véronique Préat, Maria del Carmen Dios-Viéitez & Maria J. Blanco-Prieto. (2016) Reformulating cyclosporine A (CsA): More than just a life cycle management strategy. Journal of Controlled Release 225, pages 269-282.
Crossref
Crossref
Gregori B. Romero, Anja Arntjen, Cornelia M. Keck & Rainer H. Müller. (2016) Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability. International Journal of Pharmaceutics 498:1-2, pages 217-224.
Crossref
Crossref
Annette Bak, Dennis Leung, Stephanie E. Barrett, Seth Forster, Ellen C. Minnihan, Andrew W. Leithead, James Cunningham, Nathalie Toussaint & Louis S. Crocker. (2014) Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer. The AAPS Journal 17:1, pages 144-155.
Crossref
Crossref
Ana Carmona-Ribeiro & Letícia de Melo Carrasco. (2014) Novel Formulations for Antimicrobial Peptides. International Journal of Molecular Sciences 15:10, pages 18040-18083.
Crossref
Crossref
Satomi Onoue, Hiroki Suzuki, Yoshiki Kojo, Saori Matsunaga, Hideyuki Sato, Takahiro Mizumoto, Kayo Yuminoki, Naofumi Hashimoto & Shizuo Yamada. (2014) Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability. European Journal of Pharmaceutical Sciences 62, pages 16-22.
Crossref
Crossref
Mahavir Chougule, Rakesh Tekade, Peter Hoffmann, Deepak Bhatia, Vijaykumar Sutariya & Yashwant Pathak. 2014. Biointeractions of Nanomaterials. Biointeractions of Nanomaterials
225
248
.
Naghmeh Hadidi, Farzad Kobarfard, Nastaran Nafissi-Varcheh & Reza Aboofazeli. (2013) PEGylated Single-Walled Carbon Nanotubes as Nanocarriers for Cyclosporin A Delivery. AAPS PharmSciTech 14:2, pages 593-600.
Crossref
Crossref
Satomi Onoue. (2013) Strategic Formulation Study on Dry Powder Inhalation System Based on Modulated Molecular Properties and Controlled Pharmacokinetics粉末吸入製剤開発を指向した動態制御学並びに薬剤科学の統合研究. YAKUGAKU ZASSHI 133:1, pages 93-98.
Crossref
Crossref
Adnan Nasir & Anthony Gaspari. 2013. Nanotechnology in Dermatology. Nanotechnology in Dermatology
179
186
.
Hui Zhou, Yan Gao, Xiao-Liang Cheng & Zhong-Dong Li. (2012) Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients. European Journal of Drug Metabolism and Pharmacokinetics 37:4, pages 271-278.
Crossref
Crossref
Avi Avramoff, Wahid Khan, Aviva Ezra, Anna Elgart, Amnon Hoffman & Abraham J. Domb. (2012) Cyclosporin pro-dispersion liposphere formulation. Journal of Controlled Release 160:2, pages 401-406.
Crossref
Crossref
Li Tang, Jamil Azzi, Mincheol Kwon, Marwan Mounayar, Rong Tong, Qian Yin, Robert Moore, Nikolaos Skartsis, Timothy M. Fan, Reza Abdi & Jianjun Cheng. (2012) Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. Journal of Transplantation 2012, pages 1-9.
Crossref
Crossref
Satomi Onoue, Hideyuki Sato, Kumiko Ogawa, Yoshiki Kojo, Yosuke Aoki, Yohei Kawabata, Koichi Wada, Takahiro Mizumoto & Shizuo Yamada. (2012) Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. European Journal of Pharmaceutics and Biopharmaceutics 80:1, pages 54-60.
Crossref
Crossref
Maria Dorly Del Curto, Alessandra Maroni, Luca Palugan, Lucia Zema, Andrea Gazzaniga & Maria Edvige Sangalli. (2011) Oral Delivery System for Two-pulse Colonic Release of Protein Drugs and Protease Inhibitor/Absorption Enhancer Compounds. Journal of Pharmaceutical Sciences 100:8, pages 3251-3259.
Crossref
Crossref
Samar Hamdy, Azita Haddadi, Anooshirvan Shayeganpour, Aws Alshamsan, Hamidreza Montazeri Aliabadi & Afsaneh Lavasanifar. (2011) The Immunosuppressive Activity of Polymeric Micellar Formulation of Cyclosporine A: In Vitro and In Vivo Studies. The AAPS Journal 13:2, pages 159-168.
Crossref
Crossref
Christopher R. Newey, Elias Khawam & Kathy Coffman. (2011) Two Cases of Serotonin Syndrome with Venlafaxine and Calcineurin Inhibitors. Psychosomatics 52:3, pages 286-290.
Crossref
Crossref
Einar Gude, Arne K. Andreassen, Satish Arora, Lars Gullestad, Ingelin Grov, Anders Hartmann, Torbjørn Leivestad, Arnt E. Fiane, Odd R. Geiran, Mari Vardal & Svein Simonsen. (2010) Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clinical Transplantation 24:6.
Crossref
Crossref
Satomi Onoue, Hideyuki Sato, Kumiko Ogawa, Yohei Kawabata, Takahiro Mizumoto, Kayo Yuminoki, Naofumi Hashimoto & Shizuo Yamada. (2010) Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. International Journal of Pharmaceutics 399:1-2, pages 94-101.
Crossref
Crossref
Bradford Strijack & Paul A. Keown. 2010. Immunotherapy in Transplantation. Immunotherapy in Transplantation
197
223
.
Marijke Haas Jimoh Akanbi, Eduard Post, Anita Meter-Arkema, Rick Rink, George T. Robillard, Xiaoqin Wang, Han A.B. W?sten & Karin Scholtmeijer. (2010) Use of hydrophobins in formulation of water insoluble drugs for oral administration. Colloids and Surfaces B: Biointerfaces 75:2, pages 526-531.
Crossref
Crossref
Alexandra P. Kafka, Thomas Rades & Arlene McDowell. (2009)
Rapid and specific high‐performance liquid chromatography for the
in vitro
quantification of
d
‐Lys
6
–GnRH in a microemulsion‐type formulation in the presence of peptide oxidation products
. Biomedical Chromatography 24:2, pages 132-139.
Crossref
Crossref
Shuzhong Zhang, Kazuko Sagawa, Robert D. Arnold, Elaine Tseng, Xiaodong Wang & Marilyn E. Morris. (2010) Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: In vitro and in vivo. Journal of Pharmaceutical Sciences 99:1, pages 430-441.
Crossref
Crossref
Khalid A. Al Johani, Anne M. Hegarty, Stephen R. Porter & Stefano Fedele. (2009) Calcineurin inhibitors in oral medicine. Journal of the American Academy of Dermatology 61:5, pages 829-840.
Crossref
Crossref
Margarita Mora & M. Lluïsa Sagristá. (2012) Preclinical photodynamic therapy in Spain 2: Liposome vectorization of photosensitizers; Different strategies, different outcomes. Journal of Porphyrins and Phthalocyanines 13:04n05, pages 537-543.
Crossref
Crossref
Cara K. Fraser, Stephen J. Blake, Kerrilyn R. Diener, A. Bruce Lyons, Michael P. Brown, Timothy P. Hughes & John D. Hayball. (2009) Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo. Experimental Hematology 37:2, pages 256-265.
Crossref
Crossref
Samanta E. Romero, Guadalupe Bravo, Enrique Hong, Guillermo Rojas & Antonio Ibarra. (2008) Acute, subacute and chronic effect of cyclosporin-A on mean arterial pressure of rats with severe spinal cord contusion. Neuroscience Letters 445:1, pages 99-102.
Crossref
Crossref
Diana Velluto, Davide Demurtas & Jeffrey A. Hubbell. (2008)
PEG-
b
-PPS Diblock Copolymer Aggregates for Hydrophobic Drug Solubilization and Release: Cyclosporin A as an Example
. Molecular Pharmaceutics 5:4, pages 632-642.
Crossref
Crossref